The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure-Reference-Cited by-同舟云学术

The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure

Published:2020-01-31 Issue:1 Volume:61 Page:1-6
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Gao Yang¹,Xing Changtai²,Hao Wenjun¹,Zhao Hongwei¹,Wang Lili¹,Luan Bo¹,Hou Aijie¹

Affiliation:

1. Department of Cardiology, The People's Hospital of Liaoning Province

2. Department of Cardiology, The Center Hospital Affiliated to Shenyang Medical College

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/61/1/61_19-231/_pdf

Reference23 articles.

1. 1. Aleksandrova EB, Sidorenko BA. Brain natriuretic peptide for early diagnosis of chronic heart failure in patients with preserved left ventricular ejection fraction. Kardiologiia 2012; 52: 27-32.

2. 2. Ji CL, Nomi A, Li B, Shen C, Song BC, Zhang JG. Increased plasma soluble fractalkine in patients with chronic heart failure and its clinical significance. Int Heart J 2019; 60: 701-7.

3. 3. Loretta Fala. Entresto (Sacubitril/Valsartan): first-in-class angiotensin receptor neprilysin inhibitor FDA approved for heart failure. Am Health Drug Benefits 2016; 3: 78-82.

4. 4. Tian H-P, Sun Y-H, He L, Yi YF, Gao X, Xu DL. Single-stranded DNA-binding Protein 1 abrogates cardiac fibroblast proliferation and collagen expression induced by angiotensin II. Int Heart J 2018; 59: 1398-408.

5. 5. McMurray J, Packer M, Desai A, et al. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J 2015; 36: 434-9.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis;Chinese Medical Journal;2024-05-28

2. Correlation Analysis and Diagnostic Value of Serum Homocysteine, Cystatin C and Uric Acid Levels with the Severity of Coronary Artery Stenosis in Patients with Coronary Heart Disease;International Journal of General Medicine;2023-06

3. Effects of Sacubitril–Valsartan in Patients With Various Types of Heart Failure: A Meta-analysis;Journal of Cardiovascular Pharmacology;2023-06

4. Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials;Journal of Cardiovascular Pharmacology;2023-02

5. The Impact of Noninvasive Ventilator Assisted Ventilation Nursing Combined with Mechanical Vibration on the Level of Heart Failure Indexes in ICU Patients with Acute Heart Failure;Journal of Healthcare Engineering;2022-02-26